Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Uploaded on Nov 10, 2011
U.S. Senators, clinical experts, and people with type 1 diabetes (T1D) today urged the Food and Drug Administration (FDA) to issue clear and reasonable guidance on the artificial pancreas (AP) that avoids unnecessary delays in development and delivery of a medical technology and improves the lives of millions of Americans living with this disease. Over 100K people have signed a petition to the FDA calling for swift action.